Key Highlights: Implications: NuSynth’s ₹36.5 crore seed round reflects growing investor interest in AI-enabled chemical manufacturing, where data-driven experimentation can improve proces...
Key Highlights: Implications: Anupam Rasayan’s acquisition of a 48.2% controlling stake in Bliss GVS Pharma at ₹299/share completes its forward integration into finished‑dose formulations,...
Key Highlights: Implications: The demerger splits India Glycols into three focused companies—chemicals/industrial gases (India Glycols), spirits/biofuels (IGL Spirits), and bio‑pharma/bio‑...
